# Compass Therapeutics, Inc.: Form 8-K, filed Dec 17, 2020

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2020-12-17
- Accepted by EDGAR: Dec 17, 2020, 22:02 ET
- Period: 2020-12-12
- Accession: 0001564590-20-057477
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000156459020057477/cmpx-8k_20201212.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000156459020057477/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000156459020057477/cmpx-8k_20201212.htm

Filed Dec 17, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-057477. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.